BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 14571786)

  • 21. The significance of perineural invasion as a prognostic factor in patients with gastric carcinoma.
    Duraker N; Sişman S; Can G
    Surg Today; 2003; 33(2):95-100. PubMed ID: 12616368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological features of patients who died with second primary cancer after curative resection for gastric cancer.
    Maehara Y; Tomisaki S; Emi Y; Sakaguchi Y; Kusumoto T; Ichiyoshi Y; Sugimachi K
    Anticancer Res; 1995; 15(3):1049-53. PubMed ID: 7645924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Important prognostic factors in surgically treated gastric cancer patients].
    Hiratsuka M; Iwanaga T; Furukawa H; Yasuda T; Nakano H; Nakamori S; Ohigashi H; Kameyama M; Sasaki Y; Kabuto T
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):703-8. PubMed ID: 7717727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors after surgery in patients younger than 50 years old with colorectal adenocarcinoma.
    Mäkelä J; Kiviniemi H; Laitinen S
    Hepatogastroenterology; 2002; 49(46):971-5. PubMed ID: 12143256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should scirrhous gastric carcinoma be treated surgically? Clinical experiences with 233 cases and a retrospective analysis of prognosticators.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
    Hepatogastroenterology; 2001; 48(41):1509-12. PubMed ID: 11677997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Management of patients with hepatic metastases from gastric carcinoma].
    Hiratsuka M; Yano T; Yamamoto M; Okazaki M; Kokufu I; Miyoshi H; Kimura F; Tanei T; Umemoto K; Miyashiro I; Sasaki Y; Ishikawa O
    Nihon Geka Gakkai Zasshi; 2003 Oct; 104(10):711-6. PubMed ID: 14579757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic strategy for hepatic metastasis of primary colon cancer].
    Yukawa N; Akaike M; Sugimasa Y; Takemiya S; Motohashi H
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1565-8. PubMed ID: 11707981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Postoperative recurrence of T2 stage gastric cancer].
    Yuan X; Shao Y; Cui X; Zheng C
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):499-501. PubMed ID: 11832091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of treatment for synchronous hepatic metastases from gastric cancer with special reference to long-term survivors.
    Kunieda K; Saji S; Sugiyama Y; Osada S; Sano J; Nagao N; Takahashi T; Takagi Y; Arai Y
    Surg Today; 2002; 32(7):587-93. PubMed ID: 12111514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatectomy for metastases from non-colorectal and non-neuroendocrine tumor.
    Yamada H; Katoh H; Kondo S; Okushiba S; Morikawa T
    Anticancer Res; 2001; 21(6A):4159-62. PubMed ID: 11911311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of intra-arterial infusion chemotherapy for liver metastasis from gastric cancer FEM--combination therapy of 5 FU, Epirubicin and MMC].
    Takada J; Katsuki Y; Hamada H; Tsuji Y
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2089-91. PubMed ID: 12484009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative body-weight loss and survival after curative resection for gastric cancer.
    Yu W; Seo BY; Chung HY
    Br J Surg; 2002 Apr; 89(4):467-70. PubMed ID: 11952589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastric carcinoma invading muscularis propria and macroscopic appearance.
    Maehara Y; Anai H; Moriguchi S; Watanabe A; Tsujitani S; Sugimachi K
    Eur J Surg Oncol; 1992 Apr; 18(2):131-4. PubMed ID: 1582506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor recurrence and its timing following curative resection of early gastric carcinoma.
    Otsuji E; Kuriu Y; Ichikawa D; Okamoto K; Hagiwara A; Yamagishi H
    Anticancer Res; 2003; 23(4):3499-503. PubMed ID: 12926097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and factors associated with recurrence patterns after intended curative surgery for gastric cancer.
    Wu CW; Lo SS; Shen KH; Hsieh MC; Chen JH; Chiang JH; Lin HJ; Li AF; Lui WY
    World J Surg; 2003 Feb; 27(2):153-8. PubMed ID: 12616428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-operative serum levels of sialyl Tn antigen predict liver metastasis and poor prognosis in patients with gastric cancer.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K; Ishikawa H
    Eur J Surg Oncol; 2001 Dec; 27(8):731-9. PubMed ID: 11735169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of prognostic factors in surgery of gastric cancer].
    Cavallaro A; Agresta F; Rizzo S; Di Giovanni V
    G Chir; 1989 Mar; 10(3):88-92. PubMed ID: 2518543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic disseminated tumor cells in colorectal cancer UICC stage 4 patients: prognostic implications.
    Schimanski CC; Linnemann U; Galle PR; Arbogast R; Berger MR
    Int J Oncol; 2003 Sep; 23(3):791-6. PubMed ID: 12888919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinico-pathological study on recurrent gastric cancer after curative resection].
    Takeshita K; Habu H; Sunagawa M; Saitoh N; Satoh Y; Endoh M
    Nihon Geka Gakkai Zasshi; 1988 Feb; 89(2):173-80. PubMed ID: 2834631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnitude of serosal changes predicts peritoneal recurrence of gastric cancer.
    Bando E; Kawamura T; Kinoshita K; Takahashi S; Maeda A; Osada S; Tsubosa Y; Yamaguchi S; Uesaka K; Yonemura Y
    J Am Coll Surg; 2003 Aug; 197(2):212-22. PubMed ID: 12892799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.